These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1290564)

  • 1. [Biological safety investigations of the production of human insulin by genetically engineered E. coli K-12 cells. 1. Survival capacity of the production strain in the digestive tract of Göttinger miniature swine].
    Mieschendahl M; Finkernagel K; Hunke C; Spranz E
    Zentralbl Hyg Umweltmed; 1992 Dec; 193(4):342-9. PubMed ID: 1290564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biological safety investigations of the production of human insulin by genetically-engineered E. coli K-12 cells. 3. Plasmid transfer by natural transformation and transduction].
    Mieschendahl M; Schaffrath S; Lenkeit C; Danneberg G
    Zentralbl Hyg Umweltmed; 1993 May; 194(3):262-70. PubMed ID: 8338615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biological safety investigation of the production of human insulin using genetically altered E. coli K-12 cells. 2. Plasmid transfer by mobilization and cointegrate formation under environmental conditions].
    Mieschendahl M; Finkernagel K; Schaffrath S
    Zentralbl Hyg Umweltmed; 1993 Feb; 193(5):481-93. PubMed ID: 8476500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression for commercial production of recombinant human insulin as A-chain and B-chain fusion protein in Escherichia coli through genetically engineered plasmids.
    Chakraborty C
    Indian J Pathol Microbiol; 2004 Oct; 47(4):569-73. PubMed ID: 16295400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of risks in connection with use of a recombinant E. coli strain for production of human growth hormone.
    Dalbøge H; Madsen B; Jørgensen KD; Carlsen S
    Dan Med Bull; 1988 Feb; 35(1):84-91. PubMed ID: 3277799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Implantation of a strain of "Escherichia coli" in the digestive tract of human new-borns: barrier effect against antibioresistant "E. coli" (author's transl)].
    Duval-Iflah Y; Ouriet MF; Moreau C; Daniel N; Gabilan JC; Raibaud P
    Ann Microbiol (Paris); 1982; 133(3):393-408. PubMed ID: 7049042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico prediction and validation of the importance of the Entner-Doudoroff pathway in poly(3-hydroxybutyrate) production by metabolically engineered Escherichia coli.
    Hong SH; Park SJ; Moon SY; Park JP; Lee SY
    Biotechnol Bioeng; 2003 Sep; 83(7):854-63. PubMed ID: 12889025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic engineering of human insulin].
    Shibasaki Y; Kanazawa Y
    Nihon Rinsho; 1991 Feb; 49 Suppl():737-43. PubMed ID: 2033871
    [No Abstract]   [Full Text] [Related]  

  • 10. [Survival ability of genetically engineered strains of Escherichia coli. 1. Physiological characterization and the effect of different physiochemical conditions].
    Dott W; Khoury N; Ankel-Fuchs D; Henninger W; Kämpfer P
    Zentralbl Hyg Umweltmed; 1991 May; 191(5-6):539-54. PubMed ID: 1883476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an antibiotic-free plasmid selection system based on glycine auxotrophy for recombinant protein overproduction in Escherichia coli.
    Vidal L; Pinsach J; Striedner G; Caminal G; Ferrer P
    J Biotechnol; 2008 Mar; 134(1-2):127-36. PubMed ID: 18308411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From cattle, swine, and horse insulin to human insulin: the biotechnology and genetic technology of insulin production].
    Zündorf I; Dingermann T
    Pharm Unserer Zeit; 2001 Jan; 30(1):27-32. PubMed ID: 11233180
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of synthetic proteinase inhibitors of the level of human recombinant proinsulin production, secreted by a genetically engineered strain of Bacillus subtilis].
    Parfenova EV; Popov DG; Novikov AA; Sterkin VE; Strongin AIa; Aksinenko AIu; Korenchenko OV; Fetisov VI; Martynov IV; Sokolov VB
    Bioorg Khim; 1989 Jul; 15(7):987-9. PubMed ID: 2510738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High-cell density cultivation of recombinant Escherichia coli for production of TRAIL by using a 2-stage feeding strategy].
    Zhang Y; Shen YL; Xia XX; Sun AY; Wei DZ; Zhou JS; Zhang GJ; Wang LH; Jiao BH
    Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):408-13. PubMed ID: 15971615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virulence profiles of Shiga toxin 2e-producing Escherichia coli isolated from healthy pig at slaughter.
    Zweifel C; Schumacher S; Beutin L; Blanco J; Stephan R
    Vet Microbiol; 2006 Oct; 117(2-4):328-32. PubMed ID: 16872761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulating the microbial colonization of the gastrointestinal tract by oral administration of defined Escherichia coli strains. I. Influencing the biotope by means of metabolic drift mutants of Escherichia coli.
    Blatz R; Linde K
    Acta Microbiol Hung; 1990; 37(2):145-53. PubMed ID: 2270733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a 3.3-kb plasmid of Escherichia coli O157:H7 and evaluation of stability of genetically engineered derivatives of this plasmid expressing green fluorescence.
    Sharma VK; Stanton TB
    Vet Microbiol; 2008 Dec; 132(3-4):421-7. PubMed ID: 18586417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of an ampicillin resistance gene between two Escherichia coli strains in the bowel microbiota of an infant treated with antibiotics.
    Karami N; Martner A; Enne VI; Swerkersson S; Adlerberth I; Wold AE
    J Antimicrob Chemother; 2007 Nov; 60(5):1142-5. PubMed ID: 17768176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Survival capacity of genetically altered Escherichia coli strains. 2. Survival of pure cultures in different water and soil matrices].
    Dott W; Khoury N; Ankel-Fuchs D; Henninger W; Kämpfer P
    Zentralbl Hyg Umweltmed; 1991 Sep; 192(1):1-13. PubMed ID: 1953929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of isopropanol by metabolically engineered Escherichia coli.
    Jojima T; Inui M; Yukawa H
    Appl Microbiol Biotechnol; 2008 Jan; 77(6):1219-24. PubMed ID: 17987288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.